日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study

Alirocumab联合cemiplimab治疗晚期免疫难治性转移性非小细胞肺癌：一项正在进行的多中心II期研究

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2648863
Oduah, Eziafa I; Zhang, Tian; Jung, Sin-Ho; Stinchcombe, Thomas E; Ready, Neal; Crawford, Jeffrey; Clarke, Jeffrey M; Gray, Jhanelle E; Antonia, Scott J
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

针对补体因子 H 的抗体 GT103 在难治性非小细胞肺癌中的应用：一项 1b 期剂量递增试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-55092-2
Clarke Jeffrey M, Simon George R, Mamdani Hirva, Gu Lin, Herndon James E 2nd, Stinchcombe Thomas E, Ready Neal, Crawford Jeffrey, Sonpavde Guru, Balevic Stephen, Nixon Andrew B, Campa Michael, Gottlin Elizabeth B, Li Huihua, Saxena Ruchi, He You Wen, Antonia Scott, Patz Edward F Jr
细胞生物学
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation

早期非小细胞肺癌（NSCLC）围手术期帕博利珠单抗治疗：肿瘤微环境和外周循环的常规及基于分布的免疫分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-012432
Zhang, Jingxuan; Lin, Lin; Enzor, Jennifer H; Patel, Prekshaben H; Steadman, Katelyn N; Little, Victoria E; Gu, Lin; Oduah, Eziafa I; Tong, Betty C; Antonia, Scott J; Ready, Neal E; Weinhold, Kent J
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2025
文献求助 收藏

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis

早期非小细胞肺癌（NSCLC）围手术期帕博利珠单抗治疗：安全性、有效性和探索性生物标志物分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010395
Wood, Cameron; Lyniv, Liliana; Isaacs, James M; Kaufman, Jacob M; Oduah, Eziafa I; Clarke, Jeff; Crawford, Jeffrey; Stinchcombe, Thomas; Tong, Betty C; Wang, Xiaofei; Gu, Lin; Wigle, Dennis; Dragnev, Konstantin H; Antonia, Scott J; Weinhold, Kent; Ready, Neal
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
发表日期：2025
文献求助 收藏

LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial

LRP1b缺失可预测非小细胞肺癌患者对免疫疗法的敏感性：一项基于III期CheckMate-026随机试验的分析

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0952
Armstrong, Andrew J; Dietz, Hilary; Balli, David; Geese, William J; Duan, Chunzhe; Hung, Yu-Han; Ip, Virginia; Li, Gerald; Graf, Ryon P; Ready, Neal
肺癌
肿瘤
肿瘤免疫
LRP1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

cytoGPNet: Enhancing clinical outcome prediction accuracy using longitudinal cytometry data in small cohort studies

cytoGPNet：利用小型队列研究中的纵向细胞计数数据提高临床结果预测准确性

期刊:Patterns
影响因子:7.4
doi:10.1016/j.patter.2025.101297
Zhang, Jingxuan; Sun, Liwen; Ready, Neal E; Guo, Wenbo; Lin, Lin
细胞生物学
发表日期：2025
文献求助 收藏

Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment

接受三线治疗的广泛期小细胞肺癌患者的真实世界疗效、生存结果和治疗模式

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70289
Bar, Jair; Xu, Qingqing; Karve, Sudeep; Hingorani, Pooja; Virani, Amin A; Ready, Neal E
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

cytoGPNet: Enhancing Clinical Outcome Prediction Accuracy Using Longitudinal Cytometry Data in Small Cohort Studies

cytoGPNet：利用小型队列研究中的纵向细胞计量数据提高临床结果预测准确性

期刊:
影响因子:
doi:10.1101/2025.05.01.651729
Zhang, Jingxuan; Sun, Liwen; Ready, Neal E; Guo, Wenbo; Lin, Lin
细胞生物学
发表日期：2025
文献求助 收藏

A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer

ABBV-011（一种靶向癫痫相关同源蛋白6的抗体药物偶联物）在小细胞肺癌患者中的I期首次人体研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1547
Morgensztern, Daniel; Ready, Neal; Johnson, Melissa L; Dowlati, Afshin; Choudhury, Noura; Carbone, David P; Schaefer, Eric; Arnold, Susanne M; Puri, Sonam; Piotrowska, Zofia; Hegde, Aparna; Chiang, Anne C; Iams, Wade; Tolcher, Anthony; Nosaki, Kaname; Kozuki, Toshiyuki; Li, Tianhong; Santana-Davila, Rafael; Akamatsu, Hiroaki; Murakami, Haruyasu; Yokouchi, Hiroshi; Wang, Song; Zha, Jiuhong; Li, Rui; Robinson, Randy R; Hingorani, Pooja; Jeng, Edwin E; Furqan, Muhammad
肺癌
肿瘤
肿瘤免疫
癫痫
神经科学
Human
细胞生物学
发表日期：2024
文献求助 收藏

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

一线纳武利尤单抗联合伊匹木单抗治疗转移性非小细胞肺癌，包括ECOG体能状态评分为2的患者和其他特殊人群：CheckMate 817

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006127
Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏